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The natura l history of huma n cutaneous graft-versus-
host disease (GVHD) has been described as a conse-
quence of allogeneic bone-marrow transplants, but syn-
geneic and eve n autologous marrow transplants are now 
being r ecognized as being associated with similar, albeit 
less severe, changes. The his topathologic changes of 
both acute and chronic GVHD have been reported and 
show similarit ies to other idiopathic cutaneous disor-
der s . T he T-ly mphocyte, specifically an OKT8+ cell, 
see ms to play a major role in the pathogenesis of cuta-
n eous GVHD. A recently described in vitro model of 
huma n cutaneous GVHD using skin explants co-cultured 
w ith lymphocytes holds some promise as a technique to 
further explore lymphocy te -skin interactions. 
Graft-versus- host disease (GVHD) is a clinical syndrome 
characte ri zed by cuta neous changes, gastroin testina l dysfun c-
t ion and live r dysfunction. The lymphoid and hematopoietic 
systems may be involved but usually to a lesser extent . GVHD 
develops most commonly as a sequelae of allogeneic bone-
marrow t ransplantation for aplastic anemia and leukemia , but 
it may also develop following syngeneic bone-marrow trans-
p lantation (1], autologous bone-marrow t ransplantation, blood 
t ransfusions in immunosuppressed patients [2,3], and mater-
nal-fetal t ransfe r of leukocytes to the immunodefi cient fetus 
l4]. 
Acute GVH D occurs in up to 80% of patients rece iving 
allogeneic bone-marrow t ransplants [5,6] in varying degrees of 
severi ty. Conve rsely, it does not seem to occur in 20% of 
patients rece iving simila r bone-marrow t ransplants under t he 
same condi t ions. T he reason why it occurs in some patients 
and not in others is unknown. 
GVHD deve lops in two phases- acute and chronic- which 
may or may not ove rlap and which may develop independent ly 
of each other. T he acute phase is t hought to be t he resul t of 
immunocompetent donor T lymphocytes reacting to host his-
tocompatibili ty ant igens while t he chronic phase t hat develops 
afte r a period of engraft ment seems to be produced by cells t hat 
diffe rent iate within the host [7]. 
T he cutaneous manifestations of GVHD have clinical and 
histopathologic features simila r to other cutaneous disorders, 
specifica lly, tox ic epidermal nec rolys is, lichen pl anus (LP) , and 
sc leroderma. Th is consistent development of t hese t ypes of 
skin lesions makes GVHD an importa nt model of immunolog-
ically- mediated disease [8]. Fo r it is only in GVHD, in cont rast 
to t he other diseases, t hat t he t ime of t he ini t ial event, eit her 
t he bone-marrow t ransplant or t he blood t ransfusion, is pre-
cise ly known and t he sequence of subsequen t events can be 
prospective ly moni tored. 
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CLINICAL MANIFESTATIONS 
Acute GVHD usually develops within 10- 40 days after mar-
row t ransplantation or blood transfusion, but I have obse rved 
patients who have developed acute G VHD as early as six days. 
The earliest cutaneous symptom is loca lized or genera lized 
pruritus. Discomfort or pain in t he skin elicited by pressure on 
t he palms or soles is a frequent finding. A biopsy of t he skin , 
even at t his early stage, before a n obvious rash develops, may 
show the histologic features of acute gra ft-versus-host reaction 
(GVHR) . The early phase of t he rash consists of a blanchable, 
erythematous, macular, and sometimes papular eruption with 
a predilect ion for the upper trunk, ears, hands, and feet espe-
cially the pa lms and soles. Edema and a violaceous color develop 
in t he skin of t he pinnae and periungual a reas [9] . The erupt ion 
may become generalized and blister formation may occur par-
t icularly over pressure a reas. A posit ive Nikolsky's sign can 
usua lly be elicited in the skin adjacent to t he blisters. Denu-
dation of t he skin may occur as t he epidermis separates cleanly 
from t he dermis. This occurrence of a generali zed erythematous 
erupt ion wit h blister formation is clinically simila r to toxic 
epidermal necrolysis [10] . Patients who develop t his degree of 
widespread involvement with blister formation have a high 
mortalit y rate. These skin lesions resolve with desquamation 
and marked hyperpigmentation. Scarring seems to occur only 
in s ites of denudation or wi th subsequen t bacte ria l infection. 
Acute GVHD may also occur s imultaneously or independ-
ent ly in t he liver [11] or gastrointestinal t ract [12]. The degree 
of involvement and the number of orga n systems involved is 
variable. The clinical manifestations of liver involvement in -
clude nausea, vomit ing, right upper quadrant pain , and abnor-
mal liver function tests especia lly t he se rum glutamic oxalo-
acetic transaminase and bilirubin. Gastrointestinal t ract in -
volvement is manifested by nausea, vomiting, cramping abdom-
inal pain , and watery dia rrhea. The diarrhea may be up to 
several liters per day requiring i.v. replacement of fluid. 
Chronic GVHD occurs several mont hs to years after the 
marrow t ransplant and tends to last for a longe r period of t ime 
than acute GVHD. Chronic GVHD may or may not be preceded 
by acute GVHD and it tends to involve pri~arily the skin and 
liver. It occurs in up to 30% of all long term survivors of ma rrow 
transplantation [13]. Chronic GVHD has been divided into two 
phases - lichenoid and sclerodermoid - based upon the type of 
cutaneous lesions. The lichenoid phase occurs prior to t he 
sclerodermoid phase, but t hey may occur independent ly of each 
other. Chronic GVHD has not been described to occur after 
blood t ransfusions or after syngeneic or autologous bone-mar-
row t ransplants. 
The earliest lesions of lichenoid GVHD occur around day 
100 post-marrow transplantation, but t hey have occurred as 
early as 45 days post t ransplant. These lesions are cha racterized 
by violaceous lichenoid papules and are most commonly dis-
tributed on t he palms and soles, but t hey may become gener-
alized. The lesions resemble lichen planus except t hat t he 
margins tend to be less distinct. The lesions tend to become 
conf1uent forming slight ly elevated plaques with large areas 
taking on a violaceous hue. The lesions a re mildly prurit ic and 
heal wi th inte nse hyperpigmentation analogous to LP . During 
the lichenoid phase of chronic GVHD, patients may develop a 
sicca syndrome or it may appea r later during the sclerodermoid 
phase (14] . The sicca syndrome tends to involve t he ora l [14] 
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and ocular mucous membranes [15]. The oral lesions usually 
begin as eit her ulcerations or as a whit ish membrane analogous 
to oral LP. With ti me, t here is a marked diminut ion in t he 
production of saliva. While these lesions may begin analogous 
to LP, t he end stage is more of a Sjogren 's type of pattern. 
Lesions similar to LP have not been described to occur in t he 
ocula r mucous membranes preceding t he development of the 
sicca features. Conversely, patients may develop the sicca man-
ifestations wit hout going through a clinically appa rent LP-like 
stage. 
The scle rodermoid phase of chronic GVHD is characterized 
by t he development of dermal sclerosis. The individual lesions 
are morphea- like in their appearance and texture and may 
remain as single les ions or coalesce to fo rm large lesions cov-
ering t he t runk or extremit ies. The cuta neous appendages may 
be lost and t here a re usually a reas of hyper- and hypopigmen-
tation similar to t hat seen in scleroderma. J oint cont ractures 
and recurrent pyoderma a re common sequelae (16]. Lesions 
t hat resemble poikiloderma, bullous lesions [17], and vascular 
t umors [18] have been desc ribed in chronic GVHD. 
Chronic G VHD may progress, stabilize, or spontaneously 
resolve. I have obse rved a cephalad to caudad sequence of 
spontaneous reso lut ion of sclerosis in seve ra l patients. The 
cont ractu res resolved and t here was reversal of t he dysfunction 
of t he joints. 
PATHOLOGY 
The sequence of pathologic features occurring in acute 
GVHR in the skin have been documented by biopsies of pa-
tients at t he t ime of a ras h [19] and by se rial biopsies from t he 
t ime of t ransplantation. These studies have shown that the 
earliest change is a vacuolar alteration of t he cytoplasm of t he 
cells in the basal cell layer of the epidermis and the ha ir follicle 
epithelium. There is usually an associated inf1ammatory cell 
infilt rate surrounding the blood vessels in t he superficia l 
p lexus, but early on t his is qui te spa rse. These early inflam-
matory cells appear to be lymphocytes on light microscopy. 
These lymphocytes are then seen wit hin the epidermis primar-
ily in t he lower layers assoc iated with mild spongios is. Individ-
ual dyskeratotic squamous cells t hen appear in the basal cell 
layer a nd lower stratum malp ighii and may be associated with 
a contiguous lymphocyte (Fig 1). This appos ition of a dysker-
atotic squamous cell and a lymphocyte has been described as a 
mummified cell and a satelli te lymphocyte [11 ,20] . However, 
t his dyskeratotic cell with an adjacent lymphocyte is not spe-
cific for GVHD and may also be seen in LP, lupus erythema-
tosus, and secondary syphili s. It has not been proven whether 
t he lymphocyte attaches to t he squamous cell prior to the 
deve lopment of dys keratos is or a fter it has occurred. As t he 
reaction progresses, t he vacuolar a lteration increases and a 
subepidermal vesicle develops. With increasing severi ty, the 
epidermis may become completely separated froin t he dermis. 
In the papula r and upper reticuLar dermis t here is marked 
endothelia l cell swelling and usua lly some extravasation of 
erythrocytes. The hemorrhage is probably due to thrombocy-
topenia or incompetent vessels as no vasculitis is seen. 
A grading system has been deve loped to fo llow the progress 
of t he histopathologic changes in acute cuta neous GVHR and 
is based upon the degree of epidermal alteration [19]. In prac-
tice this grading system has worked well. However, most of our 
patients have fallen into grade 2 despi te a wide range of clinical 
severi ty. We recent ly evaluated a series of patients in this 
histologic grade 2 category and found that there was a direct 
correlation between t he number of lymphocytes in the epider-
mis and dermis and the subsequent development of more severe 
GVHD. We a lso found that t he ea rlier t he development of 
cuta neous G VHR after t ransplantation the greater t he likeli -
hood of the development of more severe GVHD [21] . 
With resolu t ion of acute cuta neous G VHR, t he basa l ce ll 
layer is reformed, t he dyskeratotic squamous cells migrate 
FI G 1. Acute gra ft-versus- host reaction. The biopsy is from t he a rm 
of a 22-year-old woman 35 days post allogeneic ma rrow t ranspla nt 
being treated wi th prednisone and cyclosporine A. The specimen shows 
mild hyperkeratos is, mild hypergranulosis, acanthosis, vacuolar alter-
ation of t he basa l cell layer, dyskeratosis, exocytosis, and a mild 
scattered lymphocytic infilt rate in t he papillary dermis (hematoxylin -
eosin, x 140). 
upward and are shed in the stratum corneum, and the inflam-
matory infil t rate diminishes. The endothelial cell swelling sub-
sides and melanophages appear in the papillary dermis. There 
is no loss of elastic t issue. The histopathologic changes that 
occur in GVHD that develops subsequent to blood t ransfusions 
or syngeneic or autologous marrow t ransplants are similar to 
that described above but are genera lly much less severe. 
The histopathologic features of lichenoid chronic GVHD are 
similar to that seen in idiopathic LP: hyperkeratosis, hyper-
granulosis, acanthosis, vacuolar alteration of the cytoplasms of 
the basal cell layer , dyskeratosis, colloid bodies, and a band-
like inflammatory infil trate in t he papillary dermis in direct 
apposit ion to the epidermis. The infi lt rate is predominant ly 
composed of lymphocytes or mononuclear cells but t here are 
also melanophages and a few plasma cells and eosinophils at 
times (Fig 2). The intensity of the infi lt rate is less in lichenoid 
GVHD than in idiopathic LP. With resolut ion, t he epidermis 
appea rs normal and there are numerous melanophages in the 
papillary dermis. 
Sclerodermoid GVHD has features that are similar to scle-
roderma mani fested predominant ly by sclerosis of a t hickened 
reticular dermis. The distinction between the papillary and 
reticular dermis may be lost wi th the papillary dermis becoming 
qui te sclerotic. The cutaneous appendages become encased in 
the collagen and may disappear. There is a variable perivascular 
and periadnexa l infiltrate composed predominantly of lympho-
cytes wi th occasional mononuclear cells and plasma cells. T he 
overlying epidermis may show a pattern similar to t hat seen in 
the lichenoid phase, but usua lly wi th less acant hosis. Metana-
phages are usually present in the papillary dermis just beneath 
the epidermis (Fig 3). I have not seen inflammatory cells at t he 
dermal-subcutaneous junction in sclerodermoid GVHD analo-
gous to t hat seen in morphea [22). 
Electron microscopic examination of t he skin in acute GVHR 
has demonstrated degeneration of keratinocytes with aggrega-
tion of the tonofilaments and cytoplasmic organelles, cyto-
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FIG 2. L ichenoid chron ic graft-versus- host reaction. T he biopsy is 
from the leg of a 15-year-old gi rl 283 days post a lloge neic mar row 
transplant bei ng treated wit h pred nisone. T he specimen shows marked 
hyperke ratosis, marked hypergranu losis, aca nthosis in a saw-tooth 
pattern , vacuolar alteration of t he basal cell layer, occasional dyske ra-
tos is, exocytosis, and a mi ld infi lt rate in the papi lla ry de rmis te nding 
to form a band at t he de rma l-epidermal junction (hematoxylin-eosin, 
X 140). 
F IG 3. Sclerodermo id chronic graft -ve rsus- host reaction. T he biopsy 
is from the shoulder of a 13-year-o ld boy one year post a llogeneic 
transplant. T he specimen shows hyperkeratosis, fl attenin g of the rete, 
foca l vacuolar alte ration and squamatization of the basal cell laye r, and 
papillary derma l sclerosis with loss of t he junction between the papi l-
lary and reticular de rmis (hematoxylin-eosin, X 140). 
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p lasmic vacuolization, and loss ofdesmosomes [4,23,24]. T hese 
degenerating ce ll s occasiona lly were phagocytized by adjacent 
keratinocytes [23). Direct contact between degenerating kerat-
inocytes and lymphocytes was observed [4,24]. Both point and 
broad zone contacts between these cells were seen [24]. T hese 
studies a re consistent with the hypothesis of an aggressor or 
cytotoxic lymphocyte as a prime mediator in t he pathogenesis 
of GVHD [4,11 ,20,24 ]. 
Contacts between Lange rhans cells or melanocytes were not 
observed by Rozman eta! [24) in t heir one case of acute G VHD. 
However, in the study by Claudy et al [25], an in teraction by 
broad contacts between melanocytes and lymphocytes in both 
acute and chronic GVHD was observed. They fou nd in t he 
clinically hyperpigmented skin melanocytes wit h numerous 
melanosomes and cytoplasmic lipid droplets. In hypopigmented 
skin they observed degenerating melanocytes wit h a few small 
melanosomes and an increased number of lipid droplets. T hey 
postulated t hat du ring G VHD t here is an initial stimulation of 
the melanocytes wi th an increased production of melanosomes 
followed by degeneration of these cells. 
Electron microscopy of the lichenoid p hase of chronic G VHD 
has demonstrated similar keratinocyte degeneration to that 
seen in acute GVHD but it is usua lly confined to the basal cell 
layer region or lower 1/3 of the epidermis [26]. Fractures and 
dup lication of t he basal membrane is seen but the hemides-
mosomes seem to re main intact [26]. Point and broad contacts 
between lymphocytes and keratinocytes were seen. T here is a 
widening of t he lamina Iucida and a paucity of anchoring 
fil aments [26]. No alterations were seen in melanocytes or 
Langerhans cells by some aut hors but t hey have been observed 
by others [25,27] T here appears to be an increased synthetic 
activity of the intact keratinocytes manifested by abundant 
endoplasmic reticulum , numerous mitochondria and free ribo-
somes. Colloid bodies were present in the epidermis and papil-
lary dermis. T hese changes suggest an ongoing destruction of 
keratinocytes in concert wit h an increased synthetic activity 
analogous to that seen in lichen planus [26]. 
T he sclerodermoid phase of chronic GVHD shows epidermal 
changes similar to that seen in t he lichenoid phase suggesting 
a similar mechanism or an orderly t ransition from one phase 
to the next [28]. T he sclerosis p redominates in the superfic ial 
dermis with collagen fibers of irregular diameter in association 
with active fibroblasts, mast cells, macrophages, and lympho-
cytes [26,28). In addi t ion , t here appears to be an increased 
amoun t of type III procollagen in the upper 1/3 of the dermis as 
demonstrated by ant ibody techniques in the early scleroder-
moid p hase and a transit ion to type I procollagen in t his same 
area in the late sclerodermoid phase [28]. 
These features differ from scleroderma in t hat t he process 
seems to be predominant in the upper dermis in GVHD and 
predominant in t he lower ret icula r dermis or subcutis in scle-
roderma [26,28]. The presence of lymphocytes in t he region of 
sclerosis suggests that an immunologic mechanism may be 
playing a role in t he production of this sclerosis [28]. 
T he deposit ion of immunoglobulin and complement in the 
skin of patients wit h acute G VHD has been inconsistent. Some 
authors have shown complement [29,30] a long the dermal-
epidermal junction in some patients and lgM [30] in others. 
Saurat eta! [31] were unable to demonstrate any immunoreac-
tant deposit ion in t heir series of patients. In a study of 22 
patients with mult iple sequent ial biopsies we were unable to 
demonstrate any consistent immunoglobulin or complement 
deposit ion in the skin suggesting that this deposition in acute 
GVHD may be an ep iphenomenon [32]. In chronic GVHD 
there seems to be a more consistent deposition of IgM, but its 
signi fica nce is unknown [31,32]. 
lmmunoperoxidase studies of the skin have shown a decrease 
in the number of epidermal Langer hans cells in both acute and 
chronic GVHD [33-36]. Decreased density of Langerhans cells 
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have been observed pret ransplant in patients wi t h aplastic 
a nemia supporting the hypothes is of bone marrow ori gin of 
these cell s [35]. The Langerhans cell s tend to reappear between 
4 and 12 months after t ranspla nt, bu t t hi s can be delayed in 
pati ents with seve re GVHD (35]. 
In GVHD t he inflammatory ce ll s in both the epidermis and 
dermis a re predominant ly T ce ll s with a greater number of 
OKT8+ cell s t ha n OKT4+ ce lls [33,34,36,37]. T his same ratio 
seems to occur in bot h acute and chronic GVHD. 
These findin gs a re consistent with the hypothesis of OKT8 
cytotoxic ce ll s playing a role in GVHD. Only a few natura l 
kill er cell s (Leu 7) have been demonstrated in the skin lesions 
confirming our unpublished findin gs. 
IN VITRO MODEL 
Recently an in vi t ro model of GVHD has been reported using 
skin expla nts co-cul tured with allogeneic lymphocytes previ-
ously primed aga inst lymphocyte a ntige ns from t he donor of 
t he skin . Afte r 1- 3 days of co-culture t he spec imens showed 
t he histopathologic features of acute GVHR: dyskeratosis, cy-
toplas mic vacuolar a lteration of the basal ce ll layer, and foca l 
areas of separation of the derma l-epidermal junction (Fig 4). 
Skin exp lants from patients prior to bone ma rrow t ransplan-
tation co-cul tured with major hi stocompatibility complex 
(MHC) compa tib le lymphocytes developed histopathologic fea-
tures of GVHR that seemed to co rrelate with the absence or 
presence of clinical GVHD in t hese patients . This model sug-
gests that primed lymphocytes conta in a cyto toxic effector cell 
t hat plays a role in the development of acute GVHR. Unprimed 
a llogeneic lymphocytes in t he same system also developed 
GVHR bu t wit h less frequency and after a longe r t ime of 
cul ture. Thi s suggests t hat an t igens wi thin the skin may be an 
init iator of the development of GVHR as well as antigens 
located on lymphocytes. This model appea rs useful for further 
studies on lymphocyte-skin inte raction in t he development of 
GVHR. It may also hold promise as an addi t iona l test for 
evaluating MH C compat ible patients who are at ri sk for the 
development of GVHD [38]. 
• 
, 
Ft G 4. In vit ro model of cuta neous gra ft -ve rsus- host reaction. A 
s kin ex pl a nt is co-cultured with primed a llogeneic MH C compatible 
lymphocytes. The specimen shows vacuolar alteration oft he basal ce ll 
layer, dyskeratosis, a nd an occasionall .vmphocyte in the upper papilla ry 
de rmis (hematoxy lin -eosin. x 14 0). 
CONCLUSIONS 
The clinica l manifestations of human cutaneous GVHD have 
been well -characterized in allogeneic bone marrow t ransplanted 
patients to date, but variat ions or associations wi t h other 
di sorders will con t inue to be described. The features of synge-
neic and autologous cutaneous GVHD need to be fur ther de-
fined with emphasis on both the differences and similarities in 
comparison wi t h the sequence of events in the a llogeneic trans-
planted patients. The corresponding histopathologic studies 
should a lso be done wi th emphasis on t he sequence of changes, 
cell types and an t igen expression within the skin . We plan to 
ut ilize the skin explant model as a method to further define the 
cell s, groups of cells, or cellular mediators that a re assoc iated 
with GVHD. The pat hogenesis ofGVHD in the skin is probably 
mediated to a large extent by T lymphocytes, bu t how they are 
ac ting and under what condi t ions is not yet defined. These and 
similar studies may be useful in not only increasing our under-
standing of GVHD, bu t may provide some insight into other 
idiopathic cutaneous disorders that share common features . 
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